In vitro evaluation of thiazolyl and benzothiazolyl Schiff bases on pig cartilage

Farmaco

Volumn 57, Issue 12, 2002, Pages 1009-1013

  Cardile, V ^a   Panico, A M ^a   Geronikaki, A ^b   Gentile, B ^a   Ronsisvalle, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cartilage; Glycosaminoglycans; Nitric oxide; Prostaglandines; Schiff bases

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; BENZOTHIAZOLYL SCHIFF BASE; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; NITRIC OXIDE; PROSTAGLANDIN E2; SCHIFF BASE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VANILLIN; INTERLEUKIN 1; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EVALUATION; IN VITRO STUDY; NONHUMAN; NOSE CARTILAGE; SWINE; TISSUE CULTURE; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; METABOLISM; NOSE SEPTUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE; DINOPROSTONE; GLYCOSAMINOGLYCANS; INTERLEUKIN-1; NASAL SEPTUM; NITRIC OXIDE; SCHIFF BASES; SWINE; THIAZOLES;

EID: 0036902947     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(02)01290-9     Document Type: Article

References (21)

1. Geronikaki A., Poroikov V., Hadjipavlou-Litina D., Filimonov D., Lagunin A., Mgonzo R. Computer aided predicting the biological activity spectra and experimental testing of new thiazole derivatives. Quant. Struct.-Act. Relat. 18:1999;16-25.
2. Hadjipiavlou-Litina D.J., Geronikaki A.A. Thiazolyl and benzothiazolyl Schiff bases as novel possible lypooxygenase inhibitors and anti inflammatory agents. Synthesis and biological evaluation. Drug Des. Discov. 15:1998;199-206.
3. Pratta M.A., Ackerman N.R., Arner E.C. Effect of Ebselen on IL-1 induced alteration in cartilage metabolism. Inflamm. Res. 47:1998;115-121.
4. Smith M.D., Parker A., Robert Thomson P.J., Ahern M.J., Coleman M. Production of IL-1 and IL-1RA in different stages of arthritis. Rev. Prat. 48:1998;S16-S23.
5. Griffin M.R., Piper J.M., Daugherty J.R., Snowden M., Ray W.A. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann. Intern. Med. 114:1991;257-263.
6. Desa F.M., Chander C.L., Howat D.W., Moore A.R., Willoughby D.A. Indomethacin and cartilage breakdown. J. Pharm. Pharmacol. 40:1988;667.
7. Shield M.J. Anti-inflammatory drugs and their effects on cartilage synthesis and renal function. Eur. J. Rheumatol. Inflamm. 13:1993;7-16.
8. Hess E.V., Herman J.H. Cartilage metabolism and anti-inflammatory drugs in osteoarthritis. Am. J. Med. 81:1986;36-43.
9. Palmoski M.J., Brandt K.D. Relationship between matrix proteoglycans content and the effects of salicylate and Indomethacin on articular cartilage. Arthritis Rheum. 26:1983;528-531.
10. Cipolletta C., Jouzeau J.Y., Pottie P.G., Presle N., Bordji K., Netter P., Terlain B. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities. Br. J. Pharmacol. 124:1998;1719-1727.
11. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum. Dis. Clin. North Am. 25:1999;269-280.
12. Taskiran D., Stefanovic Racic M., Georgescu H., Evans C.H. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem. Biophys. Res. Commun. 200:1994;142-148.
13. Jang D., Murrell G.A.C. Nitric oxide in arthritis. Free Radic. Biol. Med. 9:1998;1511-1519.
14. Cawston T. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol. Med. Today. 1998;130-137. March.
15. Bottonley K.M., Jhonson W.H., Walter D.S. Matrix metalloproteinase inhibitors in arthritis. J. Enzyme Inhib. 13:1998;79-101.
16. Needleman P., Manning P.T. Interactions between the inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) pathways: implications for therapeutic intervention in osteoarthritis. Osteoarthritis Cartilage. 7:1999;367-370.
17. Arber E.C., Pratta M.A. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum. 32:1989;288-297.
18. Hubbard J.R., Steinberg J.J., Bednar M.S., Sledge C.B. Effect of purified human interleukin-1 on cartilage degradation. J. Orthop. Res. 6:1988;180-187.
19. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantification and discrimination of sulphated glycosamminoglycans by use of dimethylmethylene blue. Biochem. Biophys. Acta. 883:1986;173-177.
20. Stone J.E., Akttar N., Botchway S., Pennock C.A. Interaction of 1,9-dimethylmethylene blue with glycosaminoglycans. Ann. Clin. Biochem. 31:1994;147-152.
21. 15N] nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.